Home/Definium Therapeutics/Daniel R. Karlin
DR

Daniel R. Karlin

Chief Medical Officer

Definium Therapeutics

Therapeutic Areas

Definium Therapeutics Pipeline

DrugIndicationPhase
DT120Major Depressive Disorder (MDD)Phase 3
DT402Autism Spectrum Disorder (ASD)Phase 2a